| P50 | author | Guohui Wan | Q82663678 |
| P2093 | author name string | Xinna Zhang | |
| | Xiongbin Lu | |
| | Franklin G Berger | |
| | Hexin Chen | |
| | Sizolwenkosi Mlotshwa | |
| | Vicki Vance | |
| P2860 | cites work | Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells | Q21195157 |
| | The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop | Q24297633 |
| | Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair | Q24297983 |
| | Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner | Q24336721 |
| | PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints | Q24527393 |
| | miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 |
| | Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control | Q24537538 |
| | p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation | Q24596239 |
| | Prospective identification of tumorigenic breast cancer cells | Q24683474 |
| | Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 | Q28218453 |
| | Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity | Q28218469 |
| | Causes and consequences of microRNA dysregulation in cancer | Q28258994 |
| | The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair | Q28278532 |
| | The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours | Q28279346 |
| | Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase | Q28283888 |
| | Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome | Q28283932 |
| | Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components | Q28290477 |
| | The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | Q28297958 |
| | In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells | Q29616498 |
| | Modulation of microRNA processing by p53 | Q29620776 |
| | A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. | Q33294239 |
| | ATM is down-regulated by N-Myc-regulated microRNA-421. | Q33667539 |
| | Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation | Q33726581 |
| | Stem cells in normal breast development and breast cancer | Q35548236 |
| | Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression | Q35568362 |
| | Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D | Q36326949 |
| | The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. | Q36617172 |
| | Identification of tumor-initiating cells in a p53-null mouse model of breast cancer | Q36762011 |
| | Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites | Q37014644 |
| | Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition | Q39747969 |
| | Tiling path genomic profiling of grade 3 invasive ductal breast cancers | Q39868704 |
| | Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma | Q40096682 |
| | Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D. | Q40406429 |
| | MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response | Q41911349 |
| | Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response | Q41967616 |
| | An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers | Q42458622 |
| | Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets | Q47848630 |
| | Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway | Q48022280 |
| | PPM1D is a potential target for 17q gain in neuroblastoma | Q52828743 |
| | The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. | Q53595739 |
| | Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways | Q61849111 |
| | Stem cell characteristics of transplanted rat mammary clonogens | Q73018903 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA damage | Q5205747 |
| P304 | page(s) | 7176-7186 | |
| P577 | publication date | 2010-07-28 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway | |
| P478 | volume | 70 | |